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Zika virus infection perturbs 
osteoblast function
Noreen Mumtaz1, Marijke Koedam2, Petra B. van den Doel1, Johannes P. T. M. van Leeuwen  2, 
Marion P. G. Koopmans1, Bram C. J. van der Eerden2 & Barry Rockx1
Zika virus (ZIKV) infection is typically characterized by a mild self-limiting disease presenting with fever, 
rash, myalgia and arthralgia and severe fetal complications during pregnancy such as microcephaly, 
subcortical calcifications and arthrogyropsis. Virus-induced arthralgia due to perturbed osteoblast 
function has been described for other arboviruses. In case of ZIKV infection, the role of osteoblasts 
in ZIKV pathogenesis and bone related pathology remains unknown. Here, we study the effect of 
ZIKV infection on osteoblast differentiation, maturation and function by quantifying activity and 
gene expression of key biomarkers, using human bone marrow-derived mesenchymal stromal cells 
(MSCs, osteoblast precursors). MSCs were induced to differentiate into osteoblasts and we found that 
osteoblasts were highly susceptible to ZIKV infection. While infection did not cause a cytopathic effect, 
a significant reduction of key osteogenic markers such as ALP, RUNX2, calcium contents and increased 
expression of IL6 in ZIKV-infected MSCs implicated a delay in osteoblast development and maturation, 
as compared to uninfected controls. In conclusion, we have developed and characterized a new in vitro 
model to study the role of bone development in ZIKV pathogenesis, which will help to identify possible 
new targets for developing therapeutic and preventive measures.
Zika virus (ZIKV) is an arthropod borne (arbo) virus and belongs to the family of Flaviviridae. Since its discov-
ery in Uganda in 1947, ZIKV has invaded different territories around the world. In 2015, ZIKV was reported in 
Brazil resulting in an epidemic of unprecedented scale in the Americas and the Caribbean1,2. Severe complica-
tions due to ZIKV infection are observed during pregnancy, including congenital abnormalities such as micro-
cephaly and subcortical calcifications3. In adults, acute symptomatic ZIKV infection is typically characterized 
by a self-limiting disease with fever, rash, conjunctivitis, myalgia and arthralgia/arthritis4. Arthralgia is reported 
in over 70% of symptomatic ZIKV cases including persistent or recurrent arthralgia for more than 30 days5,6.
Virus-induced arthralgia has previously been reported following infection with the alphaviruses Ross River virus 
(RRV) and chikungunya virus (CHIKV)7,8. Infection with RRV can perturb osteoblast function and trigger patho-
logic bone loss due to induction of interleukin-6 (IL6), and contributes to virus-induced arthritis7. Osteoblasts 
are responsible for the deposition of bone matrix and mineralization of the bone matrix. However, osteoblast 
function may be altered due to infection as reported previously for other viruses such as hepatitis C virus (HCV), 
measles virus (MV) and human immunodeficiency virus (HIV)9.
ZIKV has been detected in synovial fluid of a patient with arthralgia10, and a recent study has shown the susceptibil-
ity of an osteoblast-like cell line for ZIKV infection11. Osteoblasts originate from mesenchymal stem cells (MSCs) and 
in a recent case of miscarriage associated with ZIKV infection, ZIKV displayed tropism for fetal MSC in the perichon-
drium12. However, it is not known if MSC- derived osteoblasts are susceptible to ZIKV infection, and whether infection 
of osteoblasts affects their function thereby contributing to ZIKV pathogenesis and ZIKV-associated osteoarticular 
complications. Therefore, in the current study, we determined the susceptibility of primary human MSC-derived oste-
oblasts to infection with ZIKV and its effect on differentiation, maturation and function of these cells.
Results
ZIKV infects osteoblasts with high titers. In order to determine whether the osteoblasts are susceptible 
to infection with ZIKV, we infected osteoblast cultures with ZIKV at an moi of 5. The infected cultures did not 
show evidence for a cytopathic effect (CPE) due to ZIKV infection throughout the culture period (Supplementary 
Fig. 1). CHIKV infection resulted in extensive CPE within 4 days post-infection and as such samples were not 
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available for subsequent analyses. Similar to ZIKV, DENV infection did not result in CPE (supplementary 
Fig. 4). ZIKV infection of osteoblasts was confirmed by IFA at day 4, 7, 11 and 17 post-infection (Fig. 1 and 
Supplementary Fig. 2). Interestingly, despite using a high moi, not all cells were infected with ZIKV and the level 
of ZIKV infection remained similar throughout the experiment. However, ZIKV infected differentiating oste-
oblasts and produced high infectious titers of up to 107 TCID50/ml within 2 days post infection. No significant 
evidence of DENV infection was observed by IFA or virus titration (Supplementary Figs 3–4). Virus growth 
kinetics and IFA during the differentiation period showed that osteoblast cultures were persistently infected with 
ZIKV and shedding of infectious virions was observed over the period of three weeks post-infection for both 
donors (Fig. 1a–c).
ZIKV perturbs osteoblast differentiation and mineralization. The effect of ZIKV infection on the 
differentiation and maturation of osteoblasts was determined in infected cultures by quantifying the ALP activity 
and mineral content at different time points (Day 7, 11, 14, 18 and 21) post infection. These time points were 
selected as optimal time points for quantification of differentiation and maturation of MSC-derived osteoblasts, 
based on previous studies13,14. In ZIKV-infected osteoblasts derived from 2 different MSC donors, ALP activ-
ity was significantly reduced at day 11 post-infection compared to uninfected controls (Fig. 2a,b). Additionally, 
ZIKV infection significantly reduced osteoblast maturation in terms of mineral content in ZIKV-infected osteo-
blasts compared to uninfected controls at day 18 and 21 post-infection (Fig. 2c,d).
ZIKV affects osteoblast marker genes. To quantify the impact of ZIKV infection on the expression 
levels of key factors during ZIKV infection, which play an instrumental role in determining the osteoblasts phe-
notype, we quantified gene expression of ALP, Runt-related transcription factor 2 (RUNX2, a key transcription 
factor for osteoblast differentiation) and a classical inflammatory mediator interleukin 6 (IL6). A significant 
reduction of ALP (Fig. 3a,b) and RUNX2 expression (Fig. 3c,d) was observed in ZIKV-infected differentiating 
osteoblasts compared to uninfected controls (p value < 0.05) at day 7 post-infection. Interestingly, the levels of 
IL6 were significantly increased in infected osteoblasts (Fig. 3e,f).
Discussion
The development of arthralgia/arthritis has been a hallmark clinical symptom in several arbovirus infections, 
including ZIKV, CHIKV and dengue viruses9,15,16. While generally not considered as severe as in CHIKV infec-
tion, arthralgia/arthritis has been reported in over 70% of ZIKV cases6. In this study we investigated the sus-
ceptibility of MSC-derived osteoblasts to ZIKV infection and the effects of this infection on the phenotype of 
osteoblasts.
ZIKV readily infects differentiating primary human osteoblasts and grows to high titers within 2 days 
post infection. These findings are in line with a recent report which confirms the susceptibility of a human 
osteoblast-like cell line (HOBIT) to ZIKV11, as well as observations from other arthritogenic arboviruses such 
as CHIKV17. However, in contrast to previous studies we did not observe CPE in ZIKV-infected primary osteo-
blasts. This disparity may occur in part due to the differences in in vitro models, as primary osteoblasts derived 
from MSCs were used in the current study compared to an osteoblast-like cell line in the previous ZIKV study 
and bone fragment-derived osteoblasts used in the CHIKV study. Additionally, flavivirus replication has been 
shown to incompletely inhibit host cell macromolecular synthesis, which may result in non-cytopathic persistent 
infections18–20. In the absence of CPE, ZIKV infection resulted in a persistent infection of osteoblasts for up to 3 
weeks post infection, which suggests there may be viral persistence similar to CHIKV17.
Figure 1. Replication of ZIKV in primary osteoblasts. Culture supernatant was collected at different time 
points after infection of primary osteoblasts by ZIKV (moi = 5). (a) Growth curve kinetics of ZIKV infection 
in osteoblasts from Donor 4266 (closed circles) and Donor 3520 (open squares) during differentiation 
over the period of 3 weeks. Error bars represent the standard error of mean (S.E.M). (b) Representative 
immunofluorescent images of ZIKV-infected cells stained for ZIKV antigen (green) and nuclei (blue), and (c) 
uninfected controls at day 4 post-infection. Magnification 200x.
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Osteoblasts play an important role in bone remodeling, which is a tightly regulated process, requiring a bal-
ance in bone resorption and bone formation. Interestingly, persistent ZIKV infection had a direct effect on the 
differentiation, maturation and function of primary osteoblasts. Osteoblast differentiation comprises a highly 
coordinated sequence of events and is regulated by the activities of several key transcription factors. The key tran-
scription regulator RUNX2 plays a central role by modulating the commitment of osteoprogenitors and expres-
sion of major bone matrix genes by activating different pathways21. Following osteoblast commitment, increased 
levels of ALP are considered as the marker of osteogenic differentiation as it is one of the first functional enzymes 
observed prior to the process of mineralization. Indeed, by reducing levels of the mineralization inhibitor pyroph-
osphate, ALP activity is critical for the mineralization process22. Thus, our findings showing significantly reduced 
expressions of RUNX2 and ALP in persistently infected osteoblasts followed by diminished mineral depositions 
are of particular interest in view of ZIKV-induced alterations in the osteoblast phenotype.
In addition to bone formation biomarkers, elevated levels of IL6 comparable to that described for other arthri-
togenic arboviruses were also observed following ZIKV infection. This key pro-inflammatory mediator plays a 
pivotal role in the pathophysiology of rheumatoid arthritis, where it has been associated with stimulating neu-
trophil migration, osteoclast maturation and pannus proliferation23. During alphavirus infection, IL6 has been 
shown to indirectly disturb the bone homeostasis by stimulating the induction of bone resorption mediators in 
osteoblast cultures, resulting in bone loss and joint inflammation7,17. Future studies will focus on identifying key 
biomarkers which will allow us to predict the osteoarticular complications and disease severity following ZIKV 
infection.
In conclusion, these data clearly demonstrate that osteoblasts are susceptible to infection by ZIKV and that 
infection results in reduced differentiation and maturation of osteoblasts. The impaired function of osteoblasts 
can subsequently trigger an imbalance in bone homeostasis and induce bone-related disorders. These data 
Figure 2. Effect of ZIKV infection on osteoblast differentiation and maturation. Effect of ZIKV infection on 
osteoblast differentiation is measured by alkaline phosphatase (ALP) activity in cultures from (a) Donor 4266 
and (b) Donor 3520, and effect on mineralization is measured as a concentration of calcium present in the 
cultures from c) Donor 4266 and (d) Donor 3520. Results are compared between ZIKV -infected (white bars) 
and uninfected controls (black bars) and ALP levels are normalized against total protein. Error bars represent 
the standard error of mean. *p < 0.05.
www.nature.com/scientificreports/
4SCIENTIfIC REPORTS |         (2018) 8:16975  | DOI:10.1038/s41598-018-35422-3
warrant further studies to delineate the molecular mechanisms behind ZIKV pathogenesis in bone development 
in vitro and in vivo.
Materials and Methods
Cell cultures. Human bone marrow-derived MSCs of two healthy donors (Donor 4266 and 3520, 33 and 20 
year old males, respectively) were purchased from Lonza (PT-2501). MSCs were differentiated into osteoblasts 
as described previously24. Briefly, MSCs were cultured in αMEM medium (Gibco, Thermofisher) supplemented 
with 10% heat-inactivated fetal calf serum a (FCS, Sigma), 20 mM Hepes (Sigma), 100 U/mL penicillin (Lonza) 
and 100 µg/mL streptomycin (Thermofisher) and 1.8 mM CaCl2 (Sigma) at 37 °C and 5% CO2 in a humidified 
atmosphere. Medium on day 3 post-seeding was supplemented with 100 mM dexamethasone (dex) and 10 mM 
Figure 3. Gene expression levels of analysed genes after ZIKV infection. Gene expression of key transcription 
factors from ZIKV infected osteoblasts (white bars) versus uninfected controls (black bars) in (Left panel) 
Donor 4266 and (Right panel) Donor 3520. Gene expression was corrected for house keeping gene, GAPDH. 
Error bars represent the standard error of mean. *p < 0.05.
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β-glycerophosphate (osteogenic medium) resulting in differentiation into mineralizing osteoblasts within 2–3 
weeks14. The media were refreshed twice per week. Vero cells (African green monkey kidney epithelial cells, 
ATCC CCL-81) were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Lonza, the Netherlands) sup-
plemented with 10% heat-inactivated fetal bovine serum (FBS, Greiner Bio-One, Austria), 2 mM L-glutamin 
(Lonza), 1% sodium bicarbonate (Lonza), 1% Hepes (Lonza), 100 U/mL penicillin (Lonza) and 100 µg/mL strep-
tomycin (Lonza) at 37 °C and 5% CO2 in a humidified atmosphere.
Virus. Zika virus Suriname ZIKVNL00013 (ZIKVAS-Sur16) was isolated from a patient in The Netherlands 
(EVAg no. 011V-01621)12. This strain was previously shown to have a similar phenotype as the prototypic Asian 
lineage of ZIKV25. The virus stock used in this study was grown in Vero cells and passage number 3 was used 
for the current study. Virus titers in the supernatants were determined by endpoint titrations on Vero cells as 
described previously25. In some experiments, dengue virus (DEN 2 16681 strain) and chikungunya virus 
(CHIKV/IND/NL10/152) were included as controls. Briefly, tenfold serial dilution were inoculated onto a mon-
olayer of Vero cells in a 96-wells plate (2 × 104 cells/well). Cytopathic effect (CPE) was used as read out and 
determined at 5 days post-infection (dpi), and virus titers were calculated as the 50% tissue culture infective dose 
(TCID50) using the Spearman-Kärber method26. An initial 1:10 dilution of supernatant resulted in a detection 
limit of 101.5 TCID50/ ml.
Replication kinetics of ZIKV. MSCs were seeded three days prior to infection (day = −3). Three days 
post-seeding (day = 0), MSCs were stimulated into osteoblasts by adding osteogenic medium. After 6 hours of 
stimulation, osteoblast cultures were infected at a multiplicity of infection (moi) of 5 with ZIKVfor 1 hour at 37 °C 
in 5% CO2. The moi was based on titers determined on Vero cells. After incubation, the supernatant was removed 
and cells were washed three times with αMEM medium containing 10% heat-inactivated FCS followed by osteo-
genic medium and cells were cultured twice weekly up to three weeks depending on the experiment. Uninfected 
controls were cultured in parallel. To determine the ZIKV infectious titers produced, cell supernatants were col-
lected at different time points post infection. Supernatant was stored at −80 °C until further use. Experiments 
were performed in triplicate with two different MSC donors.
Immunofluorescence assay. Infected cells from the replication growth kinetics assay were fixed with 4% 
PFA at days 4, 7, 11 and 17 post infection, permeabilized with 70% ethanol and stained using an immunofluo-
rescence assay (IFA) as described previously25. Briefly, cells were incubated with mouse monoclonal antibody 
anti-flavivirus group antigen (MAB10216) clone D1–4G2-4-15 (Millipore, Germany) followed by staining with 
goat anti-mouse IgG conjugated with Alexa Fluor 488 (Life technologies, the Netherlands). After incubation, 
cells were mounted in ProLong® Diamond Antifade Mountant with DAPI (Life technologies, USA). Uninfected 
cells and ZIKV-infected cells stained with mouse isotype IgG2a antibody (Dako, Denmark) were used as negative 
controls. ZIKV-infected cells were identified by using a Zeiss LSM 700 confocal laser scanning microscope fitted 
on an Axio observer Z1 inverted microscope (Zeiss, Breda, the Netherlands). All images were processed using 
Zen 2010 software (Zeiss).
Alkaline phosphatase, mineralization, and protein assays. Alkaline phosphatase (ALP) and cal-
cium measurements were performed at different time points based on gene expression data as described previ-
ously13,14. Briefly, ALP activity was determined by an enzymatic reaction, where the ALP-mediated conversion 
of para-nitrophenylphosphate (pNPP) (Sigma) to paranitrophenol (PNP) during 10 min at 37 °C was measured 
at 405 nm. ALP results were adjusted for protein content of the cell lysates. For protein measurement, 200 µL of 
working reagent was added to 25 µL of cell lysate. The mixture was incubated for 30 min at 37 °C, cooled down 
to room temperature (RT) for 10 min, and absorbance was measured at 595 nm. For calcium measurements, 
cell lysates were incubated overnight with 0.24 M HCl at 4 °C. Calcium content was determined colorimetri-
cally using a calcium assay reagent prepared by combining 1 M ethanolamine buffer (pH 10.6) with 0.35 mM 
O-cresolphthalein complex one in a ratio of 1:1. All measurements were performed using a Victor2 plate reader.
Quantification of mRNA expression. RNA was extracted from ZIKV-infected and uninfected cells at 
different time points during osteoblast differentiation using TRIzol reagent (Thermo Fisher Scientific). RNA iso-
lation, cDNA synthesis, and PCR reactions were performed as described previously24. Oligonucleotide primer 
pairs were designed to be either on exon boundaries or spanning at least one intron (Table 1). Gene expression 
was corrected for the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Gene Forward primer (5′-3′) Reverse primer (5′-3′)
GAPDH CCGCATCTTCTTTTGCGTCG CCCAATACGACCAAATCCGTTG
ALP TAAAGCAGGTCTTGGGGTGC GGGTCTTTCTCTTTCTCTGGCA
RUNX2 GATTACAGACCCCAGGCAGG GGCTCAGGTAGGAGGGGTAA
IL6 AAAGAGGCACTGGCAGAAAA TTTCACCAGGCAAGTCTCCT
Table 1. Primer sequences of the analyzed genes. GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; ALP, 
Alkaline phosphate; RUX2, Runt- related transcription factor 2; IL6, Interleukin 6.
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Statistical analysis. The statistical analyses were performed using GraphPad Prism 5.01 software. All results 
are expressed as means with standard error of the mean (S.E.M.). Mann Whitney U test was used for the compar-
ison between two groups (infected versus un-infected). P value ≤ 0.05 was considered significant.
Data Availability
The data sets generated during and/or analyzed during the current study are available with the corresponding 
author, and can be accessed on reasonable request.
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